Seongho Ryu
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in ⓘ
-
- MicroRNA in disease regulation 13
- Cancer Genomics and Diagnostics 4
-
- Extracellular vesicles in disease 13
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- Co-authors
- Hyejin Choi (9 shared papers)Vivek Mittal (9 shared papers)Dingcheng Gao (8 shared papers)Linda T. Vahdat (4 shared papers)Nasser K. Altorki (5 shared papers)Anna Durrans (4 shared papers)Jianting Sheng (2 shared papers)Fuhai Li (2 shared papers)
- Journals
- Cell Reports (3 papers)Cells (3 papers)PLoS ONE (3 papers)Vaccine (2 papers)Cancer Research (2 papers)
- Partner nations
- South KoreaUnited StatesThailand
In The Last Decade
Seongho Ryu
51 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Oncology 1.3k
- Molecular Biology 1.9k
- Immunology 571
- Cell Biology 282
Countries citing papers authored by Seongho Ryu
This map shows the geographic impact of Seongho Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seongho Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seongho Ryu more than expected).
Fields of papers citing papers by Seongho Ryu
This network shows the impact of papers produced by Seongho Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seongho Ryu. The network helps show where Seongho Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Seongho Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance Hit paper breakdown → | 2015 | 1395 |
| 2 | 2012 | 234 | |
| 3 | 2002 | 234 | |
| 4 | 2013 | 126 | |
| 5 | 2015 | 118 | |
| 6 | 2013 | 102 | |
| 7 | 2020 | 98 | |
| 8 | 2001 | 88 | |
| 9 | 2016 | 80 | |
| 10 | 2019 | 75 | |
| 11 | 2020 | 72 | |
| 12 | 2015 | 63 | |
| 13 | 2019 | 62 | |
| 14 | 2019 | 50 | |
| 15 | 2020 | 42 | |
| 16 | 2020 | 39 | |
| 17 | 2012 | 36 | |
| 18 | 2020 | 35 | |
| 19 | 2022 | 29 | |
| 20 | 2018 | 27 |
About Seongho Ryu
Seongho Ryu is a scholar working on Cancer Research, Molecular Biology, Immunology and Allergy, Immunology and Oncology, having authored 54 papers that have together received 3.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Extracellular vesicles in disease (13 papers), Immunotherapy and Immune Responses (6 papers), Cancer Cells and Metastasis (5 papers), T-cell and B-cell Immunology (5 papers), Circular RNAs in diseases (4 papers), Cancer Genomics and Diagnostics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.3k citations), Molecular Biology (1.9k citations), Immunology (571 citations) and Cell Biology (282 citations). Seongho Ryu has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Hyejin Choi, Vivek Mittal, Dingcheng Gao, Linda T. Vahdat, Nasser K. Altorki, Anna Durrans, Jianting Sheng, Fuhai Li, Stephen T.C. Wong and Tina El Rayes. Their work appears in journals such as Cell Reports, Cells, PLoS ONE, Vaccine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.